Physician

Jade Garrett Anderson, M.D.

According to 2025 Medicare claims, Jade Anderson, M.D. (NPI: 1720098064) practices medical oncology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 79124-2167. Anderson is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Anderson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 627 traditional Medicare patients, billed 222,469 HCPCS/CPT codes, and received $3,018,515 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,047 prescription claims across 250 beneficiaries totaling $2,345,853 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2020 DME data shows 11 claims. Open Payments data shows 6 records totaling $267. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $674,620 to $3,018,515. Similarly, Part D prescription costs have risen steadily, from $382,965 to $2,345,853. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $674,620 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $505,351 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $550,252 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,010,520 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,603,050 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,019,054 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,151,620 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,644,803 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,518,465 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,018,515 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201524659,345$674,620
201621341,303$505,351
201722335,831$550,252
201828869,613$1,010,520
2019535198,898$2,603,050
2020478200,679$3,019,054
2021428157,444$2,151,620
2022417153,103$2,644,803
2023442172,851$2,518,465
2024627222,469$3,018,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8M$3.5M2015 Drug cost: $382,965 (USD; Tot_Drug_Cst)2016 Drug cost: $635,120 (USD; Tot_Drug_Cst)2017 Drug cost: $1,213,556 (USD; Tot_Drug_Cst)2018 Drug cost: $1,735,866 (USD; Tot_Drug_Cst)2019 Drug cost: $2,263,795 (USD; Tot_Drug_Cst)2020 Drug cost: $1,739,004 (USD; Tot_Drug_Cst)2021 Drug cost: $2,800,419 (USD; Tot_Drug_Cst)2022 Drug cost: $3,512,528 (USD; Tot_Drug_Cst)2023 Drug cost: $3,539,070 (USD; Tot_Drug_Cst)2024 Drug cost: $2,345,853 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015148943$382,965
2016134909$635,120
2017140764$1,213,556
20181931,239$1,735,866
20191771,160$2,263,795
20202081,234$1,739,004
20211911,288$2,800,419
20222201,465$3,512,528
20233131,806$3,539,070
20242501,047$2,345,853

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.2K$6.4K2015 Medicare payment: $958 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $6,414 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $417 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,352 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R38$958
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R60$6,414
2019N/R12$417
2020N/R11$1,352
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less145415$103
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less172260$50
80053Blood test, comprehensive group of blood chemicals192380$10
36415Insertion of needle into vein for collection of blood sample179343$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count200437$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate341,020$541,133
CalquenceAcalabrutinib Maleate29870$322,673
RevlimidLenalidomide20539$315,428
ErleadaApalutamide18540$267,785
ImbruvicaIbrutinib11320$92,992

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$267Pharmacosmos Therapeutics Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jade Garrett Anderson, M.D.?

Tedicare shows public-source Medicare data for Jade Garrett Anderson, M.D. (NPI 1720098064), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jade Garrett Anderson, M.D. have ACO affiliation data?

Jade Garrett Anderson, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jade Garrett Anderson, M.D.?

Jade Garrett Anderson, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Jade Garrett Anderson, M.D. have Open Payments data?

Jade Garrett Anderson, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.